Illustration 1
Illustration 2
Illustration 3

Screen Cervical Cancer Smarter.
Save Women's Lives.

AI-powered screening device to help healthcare workers detect early signs of cervical cancer accurately.

Recognized by

Apple Developer Academy

DISTP Logo
Hult Logo
NUS Logo
Lift Women Logo

On a mission to create accurate and accessible healthcare.

Mission

Cervical cancer remains high in South-East Asia.

In 2020 alone, there were over 200,000 cases and 100,000 deaths.

VIA Test, the most affordable test, is the least reliable.

Visual Inspection with Acetic Acid (VIA) is widely used, but only 66% accurate.

Cases remain high despite elimination efforts

High costs and limited access in rural areas keep case numbers high.

Introducing HerLens

Fast and Accurate Screening in Any Setting

Thoughtfully designed for healthcare workers in rural areas — easy setup, accessible, and Wi-Fi-free.

Quick & Accurate AI-Powered Screening

Capture cervical images with HerLens' mobile phone. HerLens uses AI to give instant results with confidence levels — no Wi-Fi needed. The final diagnosis is in your hand.

AI-Powered Screening Feature Image

Remote OB-GYN Specialist Consultation

Need more opinion? Consult with certified OB-GYN specialists instantly, right from the app. No delays, no barriers, no added cost.

Remote OB-GYN Consultation Feature Image

Capture High Quality Cervical Images

Snap clear, consistent images with portable hardware attached to the mobile phone. Setup takes less than a minute — no tech skills required.

High Quality Cervical Images Feature Image

Seamless & Secure Integrated Screening Data

All results are automatically saved and organized in HerLens’ secure electronic medical report (EMR). Easy access for follow-up, reports, and full privacy compliance.

Integrated Screening Data Feature Image

HerLens Comes in a Bundle, Built to Support You

We want you to have the best experience in early detection and care.

Mobile Phone

Capture cervical images, receive immediate AI analysis, and consult with specialists—all directly from your phone.

Mobile Phone
Mobile Phone
Electronic Medical Record (EMR)

Electronic Medical Record (EMR)

All patient data, securely stored and managed in one place. Simple. Centralized. Compliant.

Hardware Device

Hardware Device

A smart assistive tool designed to capture high-quality images with easy set-up.

VIA Test Kits

VIA Test Kits

Includes a speculum for clear visualization, acetic acid to highlight abnormal cells, and a cotton swab.

From Healthcare Workers to NGO—HerLens Fits In

See how HerLens supports different roles in real-world care.

Healthcare Workers

Spot early signs fast—with a simple, accurate mobile tool.

Hospitals and Clinics

Manage records, screenings, and teams—all in one place.

NGOs and Outreach

Reach more people with less effort. Scalable and easy to use.

3 Reasons to Choose HerLens

All-in-One Platform

From patient intake to AI interpretation and patient data integration — HerLens has it all.

All-in-One Platform

Affordable and Accessible

Built to work in low-resource settings, HerLens keeps costs low so more hospitals can use us.

Affordable and Accessible

Follow current VIA Test Practice

HerLens fits the current VIA workflow — no need to change how you work. We add the value.

Follow current VIA Test Practice

Global Trust. Voices on HerLens.

We are proud to support HerLens to drive positive and sustainable change.

Lori van Dam

Lori van Dam

Chief Executive Officer, Hult Prize Foundation

HerLens' breakthrough is a collective force to support screening with VIA method, in line with WHO's goal to eradicate cervical cancer.

Dr. dr. Gatot Purwoto, Sp.OG, Subsp.Onk, MPH

Dr. dr. Gatot Purwoto, Sp.OG, Subsp.Onk, MPH

Obstetrics and Gynecology Specialist, Dr. Cipto Mangunkusumo Hospital

The cancer screening technology has advanced. HerLens aims to achieve an accuracy rate of 90%.

Budi Arie Setiadi

Budi Arie Setiadi

Ex-Minister of Communication and Informatics Indonesia

This shows a commitment to developing practical tech solutions that improve the quality of life for Indonesians.

Ahmad Gamal, S.Ars., M.Si., M.U.P., Ph.D.

Ahmad Gamal, S.Ars., M.Si., M.U.P., Ph.D.

Vice Rector, University of Indonesia

Early detection of cervical cancer is crucial. One of the easiest and most affordable early detection methods is VIA Method. With HerLens, it will become more accessible, enabling IVA-DoIVA examinations across Indonesia.

Prof. Dr. dr. Laila Nuranna, Sp.OG, Subsp.Onk

Prof. Dr. dr. Laila Nuranna, Sp.OG, Subsp.Onk

Professor at the Faculty of Medicine, University of Indonesia

/_next/static/media/logo-wartakota.95501cbb.png/_next/static/media/logo-antara.b21a5a0a.png/_next/static/media/logo-detik.83ff1752.png/_next/static/media/logo-liputan6.0d88870a.svg/_next/static/media/logo-suara.042dc459.png/_next/static/media/logo-kumparan.9cc982c4.svg/_next/static/media/logo-jawapos.5f2737c9.svg/_next/static/media/logo-idntimes.e2895c10.svg

Better Screening. Stronger Care.

Screen better, reach further, save more lives.

Illustration 1
Illustration 2
Illustration 3
Illustration 4
Illustration 5